TORONTO, Nov. 4, 2025 /CNW/ – This November, in honour of Crohn’s and Colitis Awareness Month, Crohn’s and Colitis Canada is spotlighting the courage and resilience of children and youth living ...

Patients with refractory Crohn’s disease who previously received ustekinumab experienced clinical and endoscopic improvements ...

Strictly favourite Amy Dowden shocked fans yesterday as she announced she will be pulling out of this year's show for an ...

Researchers at UC San Diego have used artificial intelligence to uncover how a single broken protein link in the gut may ...

UC San Diego researchers combined artificial intelligence with molecular biology to unravel how immune cells in the gut ...

Artificial intelligence helps UCSD scientists discover a biological process connected to the bowel disease, potentially opening the door to new treatments ...

PHOENIX -- An implantable autologous cell therapy led to higher remission rates compared with standard surgical care in ...

A subgroup analysis of patients with moderately to severely active Crohn’s disease showed greater clinical and endoscopic ...

For patients newly diagnosed with Crohn’s disease, initiating anti-TNF therapy early led to better outcomes and lower overall costs than beginning with conventional treatments and escalating later.

He now aims to raise awareness for ulcerative colitis and Crohn's disease, which he was also diagnosed with. AUBURN — Kicking ...

UC San Diego researchers have resolved a decades-long debate about the role of the first Crohn’s disease gene linked to an increased risk of developing the autoimmune condition. The human digestive ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...